Unilever acquires 82% stake in GSK Bangladesh’s food & drinks business
Category: #business  By Pranali Mehta  Date: 2020-06-29
  • share
  • Twitter
  • Facebook
  • LinkedIn
Unilever acquires 82% stake in GSK Bangladesh’s food & drinks business

British-Dutch consumer goods company, Unilever, has reportedly announced its acquisition of more than 82 per cent stake in GlaxoSmithKline’s food and drinks division in Bangladesh. The company has reportedly acquired these shares from Setfirst via the block market and intends to further enhance its footprint in Asia’s fast-growing economies.

According to Unilever, Setfirst had earlier expressed its intention to sell its entire holding of 98.75 lakh shares to Unilever Overseas Holdings BV showing compliance with the stock market regulator. Sources state that GSK’s stock price was Tk 1,084 when the primary agreement was drafted in 2018.

Unilever has also expressed plans to buy GSK’s entire health food and drinks division in India as well as in 20 other Asian countries for about $3.74 billion, after having stood competition against Nestle and Coca-Cola.

For the record, GSK Bangladesh’s 9,875,144 shares have been traded on the block market for a total worth of Tk 2,020.75 crore at Tk 2,046.30 each. The block market is a stock exchange platform where a large number of securities are traded in a single transaction at a negotiated price.

Sources cite that the remaining 18 per cent of GSK Bangladesh’s shares have been held by general investors owning 2.12 per cent share, institutional investors owning 15.53 per cent, and foreign investors having a share of 0.37 per cent as of February 29, 2020, states the Dhaka Stock Exchange.

Of late, Unilever had also made an announcement disclosing the official merger of GSK Consumer Healthcare Limited with Hindustan Unilever Limited which is the largest fast-moving consumer goods business in India. Unilever envisioned to evolve its food and refreshment portfolio towards scaling growth segments through this merger.

For the uninitiated, GSK is a science-led global healthcare company with its Bangladesh division, GSK Bangladesh, beginning its journey in 2002. The company provides a wide range of products including innovative medicines, vaccines, and nutrition and oral healthcare products.

 

Source Credits:

https://www.thedailystar.net/business/news/unilever-buys-82pc-stake-gsks-health-food-division-bangladesh-1922009

  • share
  • Twitter
  • Facebook
  • LinkedIn

About Author

Pranali Mehta

Pranali Mehta    

Pranali Mehta boasts of over three years of experience as a content writer. Having completed her graduation in chemical engineering, she worked as safety & environment associate in a chemical company for a year. Harnessing her passion for writing however, Pranali deci...

Read More >>

More News By Pranali Mehta

EU closes in on banning targeted ads to avoid misuse of sensitive data
EU closes in on banning targeted ads to avoid misuse of sensitive data
By Pranali Mehta

The European Parliament recently approved the initial draft of a bill that prohibits targeted advertising based on sensitive data such as religious beliefs, sexual orientation, race, or ethnic origin. The bill especially aims to address big tech comp...

Ambulance aggregator StanPlus secures USD 20 Mn to scale its offerings
Ambulance aggregator StanPlus secures USD 20 Mn to scale its offerings
By Pranali Mehta

StanPlus, the Hyderabad-based online ambulance aggregator, has reportedly raised USD 20 million in debt and equity during a funding round that was spearheaded by HealthQuad, Kalaari Capital, as well as HealthX Capital Singapore.  The fundraisin...

R&D projects worth USD 5.5 Mn approved under India-Israel tech fund
R&D projects worth USD 5.5 Mn approved under India-Israel tech fund
By Pranali Mehta

As a part of discussions on expanding the reach of India Israel Industrial R&D along with Technological Innovation Fund, the two nations have approved three joint R&D projects costing USD 5.5 million and discussed methods to develop a bigger ...